Top Markets
Coin of the day
AREV Life Sciences Global Corp. AREV Life Sciences Global Corp.

AREV Life Sciences Global Corp.

AREV
Rang in Aktien #37036
AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005,... AREV Life Sciences Global Corp., established in Coquitlam, Canada in 2005, operates as an integrated life science discovery firm, focusing on the development and sale of functional ingredients throughout Canada. Its diverse product line includes various CBD-infused items like the anti-viral supplements Canna-Mulsion and NaturVax, NaturRelax for natural sleep support, and Natur Relief, designed for anti-inflammatory and pain relief. Additionally, the company provides white-label cannabis products, a selection of THC offerings, cannabis-based skincare, and medicinal oils and edibles. These specialized ingredients are utilized in products intended for the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical industries. AREV's solutions target health concerns such as sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, alongside other specific ailments. The company also offers nutraceutical formulations under its Bare brand and ready-to-use therapeutic food products named SUS-TAINN. Formerly known as AREV NanoTec Brands Inc., the company officially adopted its current name in August 2021.
Aktienkurs
$0.06605432
Zuletzt synchronisiert: 2024-07-23
Marktkapitalisierung
$2.08M
Veränderung (1 Tag)
-2.93%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel AREV Life Sciences Global Corp. (AREV)

Kategorie

P/B-Verhältnis für AREV Life Sciences Global Corp. (AREV)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von AREV Life Sciences Global Corp. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für AREV Life Sciences Global Corp. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber